Andrea Riccardo Filippi (Andrea R Filippi)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

Cancers

Future oncology (London, England)

Therapeutic advances in medical oncology

Expert review of anticancer therapy

University of Pavia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pavia Mar 01 2020

Italy

Full Professor

Fondazione IRCCS Policlinico San Matteo

Italy

Head of Department :: Radiation Oncology

Publications

Chandra Bortolotto, Gaia Messana, Antonio Lo Tito, Giulia Maria Stella, Alessandra Pinto, Chiara Podrecca, Riccardo Bellazzi, Alessia Gerbasi, Francesco Agustoni, Fei Han, Marcel Dominik Nickel, Domenico Zacà, Andrea Riccardo Filippi, Olivia Maria Bottinelli, Lorenzo Preda
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs. Cancers 15 (12) (2023)
Chandra Bortolotto, Gaia Messana, Antonio Lo Tito, Giulia Maria Stella, Alessandra Pinto, Chiara Podrecca, Riccardo Bellazzi, Alessia Gerbasi, Francesco Agustoni, Fei Han, Marcel Dominik Nickel, Domenico Zacà, Andrea Riccardo Filippi, Olivia Maria Bottinelli, Lorenzo Preda
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs. Cancers 15 (12) (2023)
Chandra Bortolotto, Giulia Maria Stella, Gaia Messana, Antonio Lo Tito, Chiara Podrecca, Giovanna Nicora, Riccardo Bellazzi, Alessia Gerbasi, Francesco Agustoni, Robert Grimm, Domenico Zacà, Andrea Riccardo Filippi, Olivia Maria Bottinelli, Lorenzo Preda
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results. Cancers 14 (22) (2022)
Andrea Riccardo Filippi, Rafał Dziadziuszko, Maria Rosario García Campelo, Jean-Baptiste Paoli, William Sawyer, Ignacio Esteban Díaz Pérez
DUART: durvalumab after radiotherapy in patients with unresectable, stage III NSCLC who are ineligible for chemotherapy. Future oncology (London, England) 17 (34) (2021)
Riccardo Caccialanza, Emanuele Cereda, Catherine Klersy, Mariateresa Nardi, Sara Masi, Silvia Crotti, Silvia Cappello, Valentina Caissutti, Carlotta Brovia, Federica Lobascio, Elena Formisano, Sara Colombo, Andrea Riccardo Filippi, Elisabetta Bonzano, Patrizia Comoli, Laura Catenacci, Andrea Alberti, Valeria Musella, Alessandra Ferrari, Ilaria Imarisio, Richard Tancredi, Teresa Monaco, Maria Grazia Ghi, Paolo Bossi, Paolo Pedrazzoli
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study. Therapeutic advances in medical oncology 13 (2021)
Daniela Lisini, Sara Lettieri, Sara Nava, Giulia Accordino, Simona Frigerio, Chandra Bortolotto, Andrea Lancia, Andrea Riccardo Filippi, Francesco Agustoni, Laura Pandolfi, Davide Piloni, Patrizia Comoli, Angelo Guido Corsico, Giulia Maria Stella
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach. International journal of molecular sciences 22 (16) (2021)
Pierre Loap, Alfredo Mirandola, Ludovic de Marzi, Remi Dendale, Alberto Iannalfi, Viviana Vitolo, Amelia Barcellini, Andrea Riccardo Filippi, Barbara Alicja Jereczek-Fossa, Youlia Kirova, Ester Orlandi
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence. Cancers 13 (15) (2021)
Umberto Ricardi, Mario Levis, Andrea Evangelista, Daniela Maria Gioia, Gian Mauro Sacchetti, Manuel Gotti, Alessandro Re, Michela Buglione, Vincenzo Pavone, Antonio Nardella, Luca Nassi, Manuela Zanni, Paola Franzone, Giovanni Piero Frezza, Alessandro Pulsoni, Lavinia Grapulin, Armando Santoro, Luigi Rigacci, Gabriele Simontacchi, Monica Tani, Francesco Zaja, Elisabetta Abruzzese, Barbara Botto, Vittorio Ruggero Zilioli, Delia Rota-Scalabrini, Roberto Freilone, Giovannino Ciccone, Andrea Riccardo Filippi, Pier Luigi Luigi Zinzani
Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial. Blood advances 5 (21) (2021)
Pierre Loap, Ludovic de Marzi, Alfredo Mirandola, Remi Dendale, Alberto Iannalfi, Viviana Vitolo, Amelia Barcellini, Andrea Riccardo Filippi, Barbara Alicja Jereczek-Fossa, Youlia Kirova, Ester Orlandi
Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and Perspectives. Cancers 13 (15) (2021)
Chandra Bortolotto, Andrea Lancia, Chiara Stelitano, Marianna Montesano, Elisa Merizzoli, Francesco Agustoni, Giulia Stella, Lorenzo Preda, Andrea Riccardo Filippi
Radiomics features as predictive and prognostic biomarkers in NSCLC. Expert review of anticancer therapy 21 (3) (2020)
Verane Achard, Marta Bottero, Michel Rouzaud, Andrea Lancia, Marta Scorsetti, Andrea Riccardo Filippi, Ciro Franzese, Barbara Alicja Jereczek-Fossa, Gianluca Ingrosso, Piet Ost, Thomas Zilli
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review. Acta oncologica (Stockholm, Sweden) 59 (10) (2020)
Giulia Maria Stella, Alessandra Corino, Giulia Berzero, Stefan Kolling, Andrea Riccardo Filippi, Silvia Benvenuti
Erratum: Stella, G.M. et al. Brain Metastases from Lung Cancer: Is MET an Actionable Target? Cancers 2019, 11, 271. Cancers 11 (5) (2019)
Giulia Maria Stella, Alessandra Corino, Giulia Berzero, Stefan Kolling, Andrea Riccardo Filippi, Silvia Benvenuti
Brain Metastases from Lung Cancer: Is MET an Actionable Target? Cancers 11 (3) (2019)
Patrizia Ciammella, Stefano Luminari, Luca Arcaini, Andrea Riccardo Filippi
Renewed interest for low-dose radiation therapy in follicular lymphomas: From biology to clinical applications. Hematological oncology 36 (5) (2018)

Andrea Riccardo Filippi.css-eqlu8i{font-size:small;padding-left:4px;} (Andrea R Filippi)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrea Riccardo Filippi (Andrea R Filippi)